NPR
Monday, June 18, 2012
Science Health

FDA Reform

You may need: Adobe Flash Player.

Listen to this story

Download
Earlier this month, the U.S. House and Senate passed bipartisan legislation that would avoid drug shortages by requiring pharmaceutical companies to notify the FDA when a shortage might be developing. We talk to Senator Bob Casey about the legislation and what it means.
(Senator Bob Casey (D-PA))
Senator Bob Casey (D-PA) joins us to discuss the FDA Reform Act currently before the Senate.

Earlier this month, the U.S. House and Senate passed bipartisan legislation that would avoid drug shortages by requiring pharmaceutical companies to notify the FDA when a shortage might be developing. We talk to Senator Bob Casey about the legislation and what it means.